Study reveals shared biological responses among children hospitalized with COVID-19 and other serious lung infections.
RT’s Three Key Takeaways:
- Shared Biological Patterns: Investigators identified 10 gene groups displaying similar expression patterns across severe pediatric COVID-19, respiratory syncytial virus (RSV), and pulmonary tuberculosis (PTB) infections.
- Disease Severity Markers: The research revealed 82 specific genes that differentiate mild or asymptomatic COVID-19 from severe infections in children, suggesting potential utility as clinical biomarkers.
- Addressing Global Evidence Gaps: The study provides rare data on host gene expression in African pediatric populations, establishing a baseline to understand why certain children develop life-threatening respiratory disease.
Researchers have identified distinct patterns of gene activity associated with severe COVID-19 in children that are shared with other critical lung infections, according to a study published in BMC Infectious Diseases.
According to the study authors, lower respiratory tract infections, including COVID-19, respiratory syncytial virus (RSV), and pulmonary tuberculosis (PTB), represent primary drivers of childhood morbidity and mortality, particularly across low- and middle-income nations. To evaluate pediatric immune responses, an international collaborative team led by researchers from the University of Southampton and the University of Cape Town examined gene expression profiles in blood samples from 333 children in South Africa.
Shared Biological Pathways and Severity Indicators
The research team analyzed samples from children hospitalized with severe COVID-19, RSV, and PTB infections, comparing them with cohorts of pediatric patients experiencing mild or asymptomatic COVID-19, as well as a healthy control group, according to the research release.
The analysis identified more than 5,000 genes expressed differently in children presenting with severe infections. In addition, the investigators identified 10 gene groups that showed similar activity patterns across the different lower respiratory tract infections, with functions tied to immune signaling, cellular regulation, and infection pathways.
The researchers also pinpointed 82 genes that effectively distinguished mild or asymptomatic COVID-19 cases from severe presentations, suggesting that host gene-expression profiling could potentially serve as an indicator for disease severity in healthcare settings.
“These findings provide new insights into the biological pathways involved in disease severity and highlight genes for further investigation as potential biomarkers and therapeutic targets,” said Dr Negusse Kitaba, senior research fellow at the University of Southampton and lead researcher, in a news release.
Closing Pediatric Evidence Gaps
The study addresses a longstanding lack of genomic data involving pediatric respiratory infections in underserved regions, according to the researchers.
“There’s been limited research examining biological responses to these infections in African children,” said Heather Zar, director of the South African Medical Research Council Unit on Child & Adolescent Health at the University of Cape Town and principal investigator of the three South African studies that informed the research, in a news release. “There’s also been few studies on host gene expression in infants and children with COVID-19 globally, so this study helps to close an important evidence gap.”
“This study highlights the value of international collaboration in understanding childhood respiratory disease and provides a foundation for future research into why some children develop severe infection,” said John Holloway, professor of allergy and respiratory genetics at the University of Southampton, in a news release.
According to the study team, subsequent studies involving larger cohorts of pediatric patients will be required to establish whether these gene signatures can be translated into diagnostic tools or clinical therapies.
